Moderna, Inc. (FRA:0QF)
22.79
-0.91 (-3.84%)
Aug 6, 2025, 6:52 PM CET
United States Steel Revenue
Moderna had revenue of $142.00M USD in the quarter ending June 30, 2025, a decrease of -41.08%. This brings the company's revenue in the last twelve months to $3.08B, down -39.05% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$3.08B
Revenue Growth
-39.05%
P/S Ratio
3.52
Revenue / Employee
$530.69K
Employees
5,800
Market Cap
9.23B
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
Moderna News
- 1 day ago - RFK Jr cancels $500 million in mRNA research, HHS to prioritize 'safer' vaccine alternatives - Fox News
- 1 day ago - Moderna: RSV Upside Slim, Cash Burn Heavy - Seeking Alpha
- 2 days ago - Moderna Q2 Earnings Review: Downsizing Triggers Selloff, But I'm Long-Term Bullish - Seeking Alpha
- 3 days ago - Moderna: Is Now the Time to Buy the Deep Value Dip? - FX Empire
- 3 days ago - Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus - Seeking Alpha
- 3 days ago - Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio? - Benzinga
- 5 days ago - Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent - Fast Company
- 5 days ago - Moderna making effort to stop cash outflows: Analyst - BNN Bloomberg